找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Multiple Sclerosis; Advances in Clinical Donald E. Goodkin,Richard A. Rudick Book 1996 Springer-Verlag London Limited 1996 autoimmune disea

[復制鏈接]
查看: 20729|回復: 35
樓主
發(fā)表于 2025-3-21 19:26:52 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Multiple Sclerosis
副標題Advances in Clinical
編輯Donald E. Goodkin,Richard A. Rudick
視頻videohttp://file.papertrans.cn/642/641029/641029.mp4
概述Covers the important new developments in clinical trial design and a number of important trial results that have resulted in new treatment options for patients and physicians *.Important ethical consi
圖書封面Titlebook: Multiple Sclerosis; Advances in Clinical Donald E. Goodkin,Richard A. Rudick Book 1996 Springer-Verlag London Limited 1996 autoimmune disea
描述Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives is a review of therapeutic developments for a disease that is one of the major problems in current neurologic practice. Progress in this field has been rapid and there have been important developments in clinical trial design and a number of important trial results that have resulted in new treatment options for patients and physicians. Important ethical considerations that arise with new treatments are included, as is a perspective on the emergence of MS as a treatable disease. This book is for all neurologists, primary care physicians, and patients concerned about the treatment of MS. It will also be of value to clinical epidemiologists and biostatisticians with an interest in experimental therapies for chronic disease, to immunologists with an interest in autoimmune disease, to the pharmaceutical industry and to MS societies.
出版日期Book 1996
關鍵詞autoimmune disease; brainstem; care; interferon; magnetic resonance imaging (MRI); multiple sclerosis; pri
版次1
doihttps://doi.org/10.1007/978-1-4471-1271-6
isbn_softcover978-1-85233-033-0
isbn_ebook978-1-4471-1271-6
copyrightSpringer-Verlag London Limited 1996
The information of publication is updating

書目名稱Multiple Sclerosis影響因子(影響力)




書目名稱Multiple Sclerosis影響因子(影響力)學科排名




書目名稱Multiple Sclerosis網(wǎng)絡公開度




書目名稱Multiple Sclerosis網(wǎng)絡公開度學科排名




書目名稱Multiple Sclerosis被引頻次




書目名稱Multiple Sclerosis被引頻次學科排名




書目名稱Multiple Sclerosis年度引用




書目名稱Multiple Sclerosis年度引用學科排名




書目名稱Multiple Sclerosis讀者反饋




書目名稱Multiple Sclerosis讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:30:20 | 只看該作者
https://doi.org/10.1007/978-1-4471-1271-6autoimmune disease; brainstem; care; interferon; magnetic resonance imaging (MRI); multiple sclerosis; pri
板凳
發(fā)表于 2025-3-22 02:45:37 | 只看該作者
地板
發(fā)表于 2025-3-22 04:33:43 | 只看該作者
5#
發(fā)表于 2025-3-22 11:55:21 | 只看該作者
ptions for patients and physicians *.Important ethical consiMultiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives is a review of therapeutic developments for a disease that is one of the major problems in current neurologic practice. Progress in this field has been
6#
發(fā)表于 2025-3-22 15:52:10 | 只看該作者
Book 1996 one of the major problems in current neurologic practice. Progress in this field has been rapid and there have been important developments in clinical trial design and a number of important trial results that have resulted in new treatment options for patients and physicians. Important ethical cons
7#
發(fā)表于 2025-3-22 19:22:01 | 只看該作者
Book 1996ogists, primary care physicians, and patients concerned about the treatment of MS. It will also be of value to clinical epidemiologists and biostatisticians with an interest in experimental therapies for chronic disease, to immunologists with an interest in autoimmune disease, to the pharmaceutical industry and to MS societies.
8#
發(fā)表于 2025-3-23 00:27:52 | 只看該作者
also be of value to clinical epidemiologists and biostatisticians with an interest in experimental therapies for chronic disease, to immunologists with an interest in autoimmune disease, to the pharmaceutical industry and to MS societies.978-1-85233-033-0978-1-4471-1271-6
9#
發(fā)表于 2025-3-23 03:04:26 | 只看該作者
10#
發(fā)表于 2025-3-23 07:41:13 | 只看該作者
,Mobilfunkübertragung,sit?t [SBS66] erforderlich. Deshalb wird zun?chst Diversit?t betrachtet. Abschnitt 4.2.1 erl?utert das Prinzip der Diversit?t. Die verschiedenen Arten von Diversit?t werden in Abschnitt 4.2.2 klassifiziert [KSS96].
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 14:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
台东县| 文安县| 固阳县| 蒙自县| 阿坝县| 扶绥县| 基隆市| 大悟县| 卓尼县| 大兴区| 乌兰察布市| 南部县| 边坝县| 浑源县| 晋中市| 额敏县| 洛扎县| 渑池县| 肥乡县| 江达县| 高淳县| 承德县| 玉溪市| 阳春市| 恩施市| 满城县| 清镇市| 新蔡县| SHOW| 南雄市| 辽宁省| 微博| 双辽市| 唐河县| 漯河市| 蚌埠市| 汪清县| 郓城县| 黔江区| 定边县| 台中县|